查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710268

2025年纤维蛋白胶全球市场报告

Fibrin Sealants Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年纤维蛋白胶市场规模将强劲成长。到 2029 年，这一数字将成长至 16.1 亿美元，复合年增长率为 8.1%。预测期内的增长归因于整容手术的增加、老年人口的增长、冠状动脉搭桥手术的增加、血液相关疾病的增加以及牙科手术的增加。预测期内的关键趋势包括技术进步、先进的止血技术、个人化医疗、数位健康技术和机器人辅助手术。

预计纤维蛋白胶市场的成长将受到整容手术增加的推动。整容手术专注于改善或改变个人的外貌，由于社会对美学的关注、手术技术的进步以及微创手术机会的增加，整容手术正在兴起。纤维蛋白胶用于整容手术，透过加速创伤治疗、减少出血和减少疤痕来改善手术效果和患者康復。例如，根据 CosmetAssure 2023 年 9 月的报告，抽脂手术是 2023 年最受欢迎的整容手术，共进行了 347,782 例手术，比 2022 年增长了 7%。此外，腹部整形手术增加了 5%，共进行了 170,110 例手术。整容手术的增加推动了对纤维蛋白胶的需求。

纤维蛋白胶市场的公司正在开发接触后能迅速抑制出血的止血剂。止血剂是用来刺激血液凝固并止住伤口或手术部位出血的物质。例如，2022年2月，印度止血剂製造商Swasth Kare推出了由同样位于印度的Wortham Laboratories开发的SeraSeal。 TheraSeal 是纤维蛋白胶，旨在提供近乎即时的止血效果，即使在动脉出血的情况下也是如此。它的快速作用在紧急情况下至关重要，其半透明性使外科医生能够清楚地看到出血部位，有助于在手术过程中做出更好的决策。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球纤维蛋白胶PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球纤维蛋白胶市场：成长率分析
  • 全球纤维蛋白胶市场表现：规模与成长，2019-2024
  • 全球纤维蛋白胶市场预测：规模与成长，2024-2029 年，2034 年
  • 全球纤维蛋白胶总目标市场（TAM）

第六章市场区隔

  • 全球纤维蛋白胶市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 液体
  • 修补
  • 粉末
  • 全球纤维蛋白胶市场：依技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 自体血捐献
  • 病毒灭活
  • 重组生产
  • 其他技术
  • 全球纤维蛋白胶市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 一般外科
  • 心血管外科
  • 伤口处理
  • 整形外科
  • 泌尿系统
  • 眼科手术
  • 移植手术
  • 其他用途
  • 全球纤维蛋白胶市场：依最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 其他最终用户
  • 全球纤维蛋白胶市场，依液体类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 牛液体密封剂
  • 人源液体密封剂
  • 合成液体密封胶
  • 重组纤维蛋白胶
  • 全球纤维蛋白胶市场、贴片细分、类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 牛纤维蛋白补片
  • 人源纤维蛋白贴片
  • 合成纤维蛋白贴片
  • 生物可吸收纤维蛋白贴片
  • 全球纤维蛋白胶市场，按粉末类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 牛纤维蛋白粉
  • 人类纤维蛋白粉
  • 合成纤维蛋白粉
  • 重组纤维蛋白粉

第七章 区域和国家分析

  • 全球纤维蛋白胶市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球纤维蛋白胶市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 纤维蛋白胶市场：竞争格局
  • 纤维蛋白胶市场：公司简介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • Asahi Kasei Medical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • CSL Behring Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Grifols SA
  • Sigma-Aldrich
  • Nordson Corporation
  • Integra LifeSciences Corporation
  • Shanghai RAAS Blood Products Co. Ltd.
  • Mallinckrodt Pharmaceuticals
  • Biotest AG
  • LFB Group
  • Hualan Biological Engineering Inc.
  • Corza Medical
  • Aesculap Inc.
  • Ethicon Inc.
  • CryoLife Inc.
  • VIVEX Biologics Inc.
  • MediWound Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年纤维蛋白胶市场：提供新机会的国家
  • 2029 年纤维蛋白胶市场：细分市场带来新机会
  • 2029 年纤维蛋白胶市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31847

Fibrin sealants, also known as fibrin glues or fibrin tissue adhesives, are specialized medical products used to facilitate blood clotting and tissue healing. They consist of two key components derived from human or animal blood, fibrinogen, a protein involved in blood clot formation, and thrombin, an enzyme that converts fibrinogen into fibrin, the primary substance in blood clots. These sealants are commonly employed during surgeries to manage bleeding, particularly in delicate or difficult-to-reach areas where traditional methods such as sutures or cauterization may not be effective.

The main types of fibrin sealants include liquid, patch, and powder forms. Liquid fibrin sealants are solutions of fibrinogen and thrombin that, when mixed, form a fibrin clot. These sealants are applied during surgical procedures to control bleeding and enhance tissue adhesion, with methods of application such as dripping or spraying for precise delivery to the affected area. Technologies used in the production of fibrin sealants include autologous donation, viral inactivation, and recombinant production, among others. Fibrin sealants are used in a variety of applications, including general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgeries, ophthalmic surgeries, and transplant surgery, and are utilized in hospitals, ambulatory surgical centers, and other healthcare facilities.

The fibrin sealants market research report is one of a series of new reports from The Business Research Company that provides fibrin sealants market statistics, including fibrin sealants industry global market size, regional shares, competitors with a fibrin sealants market share, detailed fibrin sealants market segments, market trends and opportunities, and any further data you may need to thrive in the fibrin sealants industry. This fibrin sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fibrin sealants market size has grown strongly in recent years. It will grow from $1.08 $ billion in 2024 to $1.17 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growth in medical tourism, growth in healthcare infrastructure, rise in elective surgical procedures, increasing prevalence of chronic diseases, and rise in demand for rapid hemostasis solutions.

The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.61 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing number of cosmetic surgeries, increasing geriatric population, increasing number of CABG, increasing blood-related disorders, and rising number of dental surgeries. Major trends in the forecast period include technological advancements, advanced hemostatic technologies, personalized medicine, digital health technologies, and robotic-assisted surgeries.

The growth of the fibrin sealants market is anticipated to be driven by the increasing number of cosmetic surgeries. Cosmetic surgeries, which focus on enhancing or altering an individual's appearance, are on the rise due to societal focus on aesthetics, advancements in surgical techniques, and greater access to minimally invasive procedures. Fibrin sealants are used in cosmetic surgeries to promote quicker wound healing, reduce bleeding, and minimize scarring, thereby improving surgical outcomes and patient recovery. For example, CosmetAssure reported in September 2023 that liposuction was the most popular plastic surgery procedure in 2023, with 347,782 procedures performed, reflecting a 7% increase from 2022. Additionally, tummy tucks saw a 5% rise, with 170,110 procedures carried out. This increase in cosmetic surgeries is boosting the demand for fibrin sealants.

Companies in the fibrin sealants market are developing hemostatic agents to rapidly control bleeding upon contact. Hemostatic agents are substances used to stop bleeding by encouraging blood clotting at wound or surgical sites. For instance, in February 2022, Swasth Kare, an India-based manufacturer of hemostatic agents, introduced SeraSeal, developed by Wortham Laboratories, also based in India. SeraSeal is a fibrin sealant designed to stop bleeding almost instantly, even in cases of arterial hemorrhage. Its rapid action is crucial in emergencies, and its translucent quality allows surgeons to clearly see the bleeding site, aiding in better decision-making during procedures.

In July 2024, Corza Medical, a US-based company specializing in innovative surgical technologies, acquired Takeda's TachoSil Manufacturing Operations in Linz, Austria, for an undisclosed amount. This acquisition enables Corza Medical to directly manage manufacturing priorities, which is expected to enhance service levels and global customer support. Takeda, a pharmaceutical company based in Japan, is involved in the development and production of fibrin sealants.

Major players in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., and Cohesion Technologies Inc.

North America was the largest region in the fibrin sealants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibrin sealants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the fibrin sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fibrin sealants market consists of sales of hemostatic agents, surgical sealants, tissue adhesives, and wound care products. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fibrin Sealants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fibrin sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fibrin sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fibrin sealants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Liquid; Patch; Powder
  • 2) By Technology: Autologous Donation; Viral Inactivation; Recombinant Production; Other Technologies
  • 3) By Application: General Surgery; Cardiovascular Surgery; Wound Management; Orthopedic Surgery; Urological Surgeries; Ophthalmic Surgeries; Transplant Surgery; Other Applications
  • 4) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Liquid: Bovine-Derived Liquid Sealants; Human-Derived Liquid Sealants; Synthetic Liquid Sealants; Recombinant Fibrin Sealants
  • 2) By Patch: Bovine-Derived Fibrin Patches; Human-Derived Fibrin Patches; Synthetic Fibrin Patches; Bioabsorbable Fibrin Patches
  • 3) By Powder: Bovine-Derived Fibrin Powder; Human-Derived Fibrin Powder; Synthetic Fibrin Powder; Recombinant Fibrin Powder
  • Companies Mentioned: Johnson & Johnson; Takeda Pharmaceutical Company Limited; Asahi Kasei Medical Co. Ltd.; Baxter International Inc.; CSL Behring
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fibrin Sealants Market Characteristics

3. Fibrin Sealants Market Trends And Strategies

4. Fibrin Sealants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Fibrin Sealants Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Fibrin Sealants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Fibrin Sealants Market Growth Rate Analysis
  • 5.4. Global Fibrin Sealants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Fibrin Sealants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Fibrin Sealants Total Addressable Market (TAM)

6. Fibrin Sealants Market Segmentation

  • 6.1. Global Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid
  • Patch
  • Powder
  • 6.2. Global Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autologous Donation
  • Viral Inactivation
  • Recombinant Production
  • Other Technologies
  • 6.3. Global Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • General Surgery
  • Cardiovascular Surgery
  • Wound Management
  • Orthopedic Surgery
  • Urological Surgeries
  • Ophthalmic Surgeries
  • Transplant Surgery
  • Other Applications
  • 6.4. Global Fibrin Sealants Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users
  • 6.5. Global Fibrin Sealants Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine-Derived Liquid Sealants
  • Human-Derived Liquid Sealants
  • Synthetic Liquid Sealants
  • Recombinant Fibrin Sealants
  • 6.6. Global Fibrin Sealants Market, Sub-Segmentation Of Patch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine-Derived Fibrin Patches
  • Human-Derived Fibrin Patches
  • Synthetic Fibrin Patches
  • Bioabsorbable Fibrin Patches
  • 6.7. Global Fibrin Sealants Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine-Derived Fibrin Powder
  • Human-Derived Fibrin Powder
  • Synthetic Fibrin Powder
  • Recombinant Fibrin Powder

7. Fibrin Sealants Market Regional And Country Analysis

  • 7.1. Global Fibrin Sealants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Fibrin Sealants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fibrin Sealants Market

  • 8.1. Asia-Pacific Fibrin Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fibrin Sealants Market

  • 9.1. China Fibrin Sealants Market Overview
  • 9.2. China Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fibrin Sealants Market

  • 10.1. India Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fibrin Sealants Market

  • 11.1. Japan Fibrin Sealants Market Overview
  • 11.2. Japan Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fibrin Sealants Market

  • 12.1. Australia Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fibrin Sealants Market

  • 13.1. Indonesia Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fibrin Sealants Market

  • 14.1. South Korea Fibrin Sealants Market Overview
  • 14.2. South Korea Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fibrin Sealants Market

  • 15.1. Western Europe Fibrin Sealants Market Overview
  • 15.2. Western Europe Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fibrin Sealants Market

  • 16.1. UK Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fibrin Sealants Market

  • 17.1. Germany Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fibrin Sealants Market

  • 18.1. France Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fibrin Sealants Market

  • 19.1. Italy Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fibrin Sealants Market

  • 20.1. Spain Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fibrin Sealants Market

  • 21.1. Eastern Europe Fibrin Sealants Market Overview
  • 21.2. Eastern Europe Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fibrin Sealants Market

  • 22.1. Russia Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fibrin Sealants Market

  • 23.1. North America Fibrin Sealants Market Overview
  • 23.2. North America Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fibrin Sealants Market

  • 24.1. USA Fibrin Sealants Market Overview
  • 24.2. USA Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fibrin Sealants Market

  • 25.1. Canada Fibrin Sealants Market Overview
  • 25.2. Canada Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fibrin Sealants Market

  • 26.1. South America Fibrin Sealants Market Overview
  • 26.2. South America Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fibrin Sealants Market

  • 27.1. Brazil Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fibrin Sealants Market

  • 28.1. Middle East Fibrin Sealants Market Overview
  • 28.2. Middle East Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fibrin Sealants Market

  • 29.1. Africa Fibrin Sealants Market Overview
  • 29.2. Africa Fibrin Sealants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Fibrin Sealants Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Fibrin Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fibrin Sealants Market Competitive Landscape And Company Profiles

  • 30.1. Fibrin Sealants Market Competitive Landscape
  • 30.2. Fibrin Sealants Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Asahi Kasei Medical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

31. Fibrin Sealants Market Other Major And Innovative Companies

  • 31.1. Grifols S.A.
  • 31.2. Sigma-Aldrich
  • 31.3. Nordson Corporation
  • 31.4. Integra LifeSciences Corporation
  • 31.5. Shanghai RAAS Blood Products Co. Ltd.
  • 31.6. Mallinckrodt Pharmaceuticals
  • 31.7. Biotest AG
  • 31.8. LFB Group
  • 31.9. Hualan Biological Engineering Inc.
  • 31.10. Corza Medical
  • 31.11. Aesculap Inc.
  • 31.12. Ethicon Inc.
  • 31.13. CryoLife Inc.
  • 31.14. VIVEX Biologics Inc.
  • 31.15. MediWound Ltd.

32. Global Fibrin Sealants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fibrin Sealants Market

34. Recent Developments In The Fibrin Sealants Market

35. Fibrin Sealants Market High Potential Countries, Segments and Strategies

  • 35.1 Fibrin Sealants Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Fibrin Sealants Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Fibrin Sealants Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer